Literature DB >> 15745939

Correlation of VEGF production with IL1 alpha and IL6 secretion by human pituitary adenoma cells.

S A Borg1, K E Kerry, J A Royds, R D Battersby, T H Jones.   

Abstract

OBJECTIVES: Vascular endothelial growth factor (VEGF) is considered to be the most important angiogenic factor involved in the neovascularisation of solid tumours. Regulatory molecules include cytokines and growth factors. Interleukin (IL)1 and IL6 have both been shown to regulate VEGF levels in a variety of tissues. The role of cytokines in the pathogenesis of pituitary tumours remains unclear. We have examined the expression of VEGF and its relationships with IL1 and IL6 in the human pituitary tumour cell line HP75 and a series of human pituitary tumours. We have also looked at the relationship of tumour volume and invasive status to VEGF secretion.
METHODS: Surgically resected tumours were routinely cultured in single-cell suspension at 200 K/well (standard unit for culture of dispersed primary pituitary adenoma cells). We measured VEGF, IL1 alpha and IL6 levels by ELISA. Tumour volume and invasion grade were assessed by preoperative magnetic resonance imaging.
RESULTS: VEGF was detected in conditioned medium of HP75 cells (900+/-52 pg/ml) and in 82% of tumours tested (range 26-16 464 pg/ml). Tumour volume and secretion of VEGF were significantly associated with levels of IL6 (volume, P = 0.056; VEGF, P < 0.001 (P values based on Spearman's test)) and IL1 alpha produced (volume, P < 0.005; VEGF, P < 0.001). Invasive tumours showed a higher basal secretion of VEGF that that of the non-invasive type; however, this difference was not significant. Addition of exogenous IL1 alpha, but not IL6, significantly increased VEGF production.
CONCLUSIONS: The significant associations between VEGF and the levels of IL6 and IL1 alpha suggest an important role for these cytokines in the development of these tumours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15745939     DOI: 10.1530/eje.1.01843

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

Review 1.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

2.  Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence.

Authors:  Ruth Sánchez-Ortiga; Laura Sánchez-Tejada; Oscar Moreno-Perez; Pedro Riesgo; Maria Niveiro; Antonio M Picó Alfonso
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

3.  Influence of growth and transcriptional factors, and signaling molecules on early human pituitary development.

Authors:  Mirna Bazina; Katarina Vukojevic; Damir Roje; Mirna Saraga-Babic
Journal:  J Mol Histol       Date:  2009-11-17       Impact factor: 2.611

Review 4.  Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.

Authors:  Juergen Bauditz; Herbert Lochs
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

5.  Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

Authors:  Tao Lu; Liping Tian; Yulong Han; Michael Vogelbaum; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

6.  Cell proliferation, apoptosis, and angiogenesis in non-functional pituitary adenoma: association with tumor invasiveness.

Authors:  Maliheh Ghadir; Mohammad E Khamseh; Mahshid Panahi-Shamsabad; Mohammad Ghorbani; Hamideh Akbari; Ali Zare Mehrjardi; Maryam Honardoost; Bahram Jafar-Mohammadi
Journal:  Endocrine       Date:  2020-07-12       Impact factor: 3.633

7.  High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097.

Authors:  Wei He; Leopoldo Luistro; Daisy Carvajal; Melissa Smith; Tom Nevins; Xuefeng Yin; James Cai; Brian Higgins; Kenneth Kolinsky; Christine Rizzo; Kathryn Packman; David Heimbrook; John F Boylan
Journal:  Mol Oncol       Date:  2011-01-21       Impact factor: 6.603

8.  Pathogenesis analysis of pituitary adenoma based on gene expression profiling.

Authors:  Weimin Wang; Zhiming Xu; Li Fu; Wei Liu; Xingang Li
Journal:  Oncol Lett       Date:  2014-10-13       Impact factor: 2.967

9.  Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population.

Authors:  Vesna Gorenjak; Dwaine R Vance; Alexandros M Petrelis; Maria G Stathopoulou; Sébastien Dadé; Said El Shamieh; Helena Murray; Christine Masson; John Lamont; Peter Fitzgerald; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

10.  Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours.

Authors:  Markus Dehnhardt; Christoph Palm; Andrea Vieten; Andreas Bauer; Uwe Pietrzyk
Journal:  J Neurooncol       Date:  2007-05-12       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.